Growth Metrics

Neuronetics (STIM) Cash from Financing Activities (2017 - 2026)

Neuronetics (STIM) reported Cash from Financing Activities of -$5.6 million for Q1 2026, down 129.39% year-over-year from $19.0 million in Q1 2025, and down 441.98% on a QoQ basis from -$1.0 million in Q4 2025.

Neuronetics (STIM) has 10 years of Cash from Financing Activities data on file, last reported at -$5.6 million in Q1 2026.

  • Quarterly Cash from Financing Activities fell 129.39% year-over-year to -$5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.3 million (down 77.76% YoY) and the FY2025 annual result came in at $35.8 million, up 626.59% from the prior year.
  • Cash from Financing Activities eased to -$5.6 million in Q1 2026 per STIM's latest filing, from -$1.0 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $22.3 million in Q4 2023 and bottomed at -$5.6 million in Q1 2026.
  • The 5-year median for Cash from Financing Activities is $127500.0 (2022), against an average of $5.2 million.
  • Peak annual rise in Cash from Financing Activities reached 8985.71% in 2023, while the deepest fall reached 720.0% in 2023.
  • Tracing STIM's Cash from Financing Activities over 5 years: stood at $245000.0 in 2022, then jumped by 8985.71% to $22.3 million in 2023, then slumped by 57.04% to $9.6 million in 2024, then plunged by 110.76% to -$1.0 million in 2025, then plunged by 441.98% to -$5.6 million in 2026.
  • Per Business Quant, the three latest STIM Cash from Financing Activities figures stand at -$5.6 million (Q1 2026), -$1.0 million (Q4 2025), and $17.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 17.31 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.51 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 21.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -97.90 Mn
10 Neuronetics 3.26 Mn -6.42 Mn 16.15 Mn -5.58 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -5.58 Mn
Mar 31, 2026 -5.58 Mn
Dec 31, 2025 -1.03 Mn
Dec 31, 2025 -1.03 Mn
Sep 30, 2025 17.90 Mn
Sep 30, 2025 17.90 Mn
Jun 30, 2025 1,000.00
Jun 30, 2025 1,000.00
Mar 31, 2025 18.98 Mn
Mar 31, 2025 18.98 Mn
Dec 31, 2024 9.56 Mn
Dec 31, 2024 9.56 Mn
Dec 31, 2023 22.26 Mn
Dec 31, 2023 22.26 Mn
Jun 30, 2023 -62,000.00
Jun 30, 2023 -62,000.00
Mar 31, 2023 499,000.00
Mar 31, 2023 499,000.00
Dec 31, 2022 245,000.00
Dec 31, 2022 245,000.00
Jun 30, 2022 10,000.00
Jun 30, 2022 10,000.00
Mar 31, 2022 -48,000.00
Mar 31, 2022 -48,000.00
Dec 31, 2021 32,000.00
Dec 31, 2021 32,000.00
Sep 30, 2021 100,000.00
Sep 30, 2021 100,000.00
Jun 30, 2021 711,000.00
Jun 30, 2021 711,000.00
Mar 31, 2021 82.16 Mn
Mar 31, 2021 82.16 Mn
Dec 31, 2020 56,000.00
Dec 31, 2020 56,000.00
Sep 30, 2020 410,000.00
Sep 30, 2020 410,000.00
Jun 30, 2020 48,000.00
Jun 30, 2020 48,000.00
Mar 31, 2020 1.86 Mn
Mar 31, 2020 1.86 Mn
Dec 31, 2019 100,000.00
Dec 31, 2019 100,000.00
Sep 30, 2019 443,000.00
Sep 30, 2019 443,000.00
Jun 30, 2019 470,000.00
Jun 30, 2019 470,000.00
Mar 31, 2019 1.41 Mn
Mar 31, 2019 1.41 Mn
Dec 31, 2018 460,000.00
Dec 31, 2018 460,000.00
Sep 30, 2018 97.27 Mn
Sep 30, 2018 97.27 Mn
Jun 30, 2018 -494,000.00
Jun 30, 2018 -494,000.00
Mar 31, 2018 -199,000.00
Mar 31, 2018 -199,000.00
Dec 31, 2017 5.01 Mn
Dec 31, 2017 5.01 Mn
Sep 30, 2017 14,000.00
Sep 30, 2017 14,000.00